Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells

Photochemistry and Photobiology

Volumn 76, Issue 5, 2002, Pages 514-517

  Wagner, Stephen J ^a   Skripchenko, Andrey ^a   Thompson Montgomery, Dedeene ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLMETHYLENE BLUE; DYE; MEPACRINE; METHYLENE BLUE; NUCLEIC ACID; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CELL MEMBRANE; CELL STRUCTURE; CONCENTRATION (PARAMETERS); DRUG ABSORPTION; ERYTHROCYTE; EXTRACELLULAR SPACE; HEMOLYSIS; LIGHT; LIGHT ABSORPTION; MEMBRANE BINDING; NONHUMAN; VESICULAR STOMATITIS VIRUS; VIRUS INACTIVATION;

BLOOD PRESERVATION; DRUG INTERACTIONS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOLYSIS; LIGHT; METHYLENE BLUE; PHOTOSENSITIZING AGENTS; PROTEIN BINDING; QUINACRINE; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS INACTIVATION;

VESICULAR STOMATITIS VIRUS;

EID: 0036878757     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2002)076<0514:QEVSVI>2.0.CO;2     Document Type: Article

References (31)

1. Schreiber, G. B., M. P. Busch, S. H. Kleinman and J. J. Korelitz (1996) The risk of transfusion-transmitted viral infections. N. Engl. J. Med. 334, 1685-1689.
2. NHLBI (2000) In vitro inactivation of viruses in blood components, RFA HL-00-010, 18 January 2000.
3. Dodd, R. Y., E. P. Norari and S. L. Stramer (2002) Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42, 975-979.
4. O'Brien, J. M., R. R. Montgomery, W. H. Burns, D. K. Gaffney and F. Sieber (1990) Evaluation of merocyanine 540-sensitized photo-irradiation as a means to inactivate enveloped viruses in blood products. J. Lab. Clin. Med. 116, 439-447.
5. Neyndorff, H. C., D. L. Bartel, F. Tufaro and J. G. Levy (1990) Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood. Transfusion 30, 485-490.
6. Horowitz, B., S. Rywkin, H. Margolis-Nunno, B. Williams, N. Geacintov, A. M. Prince, D. Pascual, G. Ragno, C. R. Valeri and T. Huima-Byron (1992) Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AlPc) sulfonates. Blood Cells 18, 141-149.
7. Wagner, S. J., J. R. Srorry, D. A. Mallory, R. R. Stromberg, L. E. Benade and L. I. Friedman (1992) Red cell membrane alterations associated with virucidal methylene blue phototreatment. Transfusion 33, 30-36.
8. Ben-Hur, E., S. Rywkim, I. Rosenthal, N. E. Geacintov and B. Horowitz (1995) Virus inactivation in red cell concentrates by photosensitization with phthalocyanines: protection of red cells bur not vesicular stomatitis virus with a water-soluble analogue of vitamin E. Transfusion 35, 401-406.
9. Moor, A. C., A. van der Veen, A. E. Wagenaars-van Gompel, T. M. Dubbelman, J. VanSteveninck and A. Brand (1997) Shelf-life of photodynamically sterilized red cell concentrates with various numbers of white cells. Transfusion 37, 592-600.
10. Wagner, S. J., A. Skripchenko, D. Robinette, D. A. Mallory and L. Cincotta (1998) Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue. Transfusion 38, 729-737.
11. Prince, A. M., D. Pascual, D. Meruelo, L. Liebes, Y. Mazur, E. Dubovi, M. Mandel and G. Lavie (2000) Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericin. Photochem. Photobiol. 71, 188-195.
12. Okunaka, T., M. L. Eckhauser, H. Kato, A. Bomaminio, H. Yamamoto, K. Aizawa, M. M. Sarasua and K. A. Koehler (1992) Correlation between photodynamic efficacy of differing porphyrins and membrane partitioning behavior. Lasers Surg. Med. 12, 98-103.
13. Skripchenko, A. and S. J. Wagner (2000) Photoinactivation of leukocytes in erythrocyte suspensions: comparison of methylene blue and dimethylmethylene blue. Transfusion 40, 968-975.
14. Wagner, S. J., A. Skripchenko, J. C. Pugh, D. B. Suchmann and M. K. Ijaz (2001) Duck hepatitis B photoinactivation by dimethylmethylene blue in RBC suspensions. Transfusion 41, 1154-1158.
15. Hagmar, P., S. Pierrou, P. Nielsen, B. Nordén and M. Kubista (1992) Ionic strength dependence of the binding of methylene blue to chromatin and calf thymus DNA. J. Biomol. Struct. Dyn. 9, 667-679.
16. Wagner, S. J., A. Skripchenko, D. Robinette, J. W. Foley and L. Cincotta (1998) Factors affecting virus photoinactivation by a series of phenothiazine dyes. Photochem. Photobiol. 67, 343-349.
17. Mohammad, T. and H. Morrison (1999) Photonuclease activity of Taylor's blue. Bioorg. Med. Chem. Lett. 9, 2249-2254.
18. Dise, C. A., J. W. Butch and D. B. P. Goodman (1982) Direct interaction of mepacrine with erythrocyte and platelet membrane phospholipid. J. Biol. Chem. 257, 4701-4704.
19. Volpi, M., R. I. Sha'afi, P. M. Epstein, D. M. Andrenyak and M. B. Feinstein (1981) Local anesthetics, mepacrine, and propranol are antagonists of calmodulin. Proc. Natl. Acad. Sci. USA 78, 795-799.
20. Hays, C. W. (2000) The United States Army and malaria control in World War II. Parasitologia 42, 47-52.
21. Hogman, C. F., L. Eriksson, J. Gong, A. B. Hogman, K. Vikholm, J. Debrauwere, J. M. Payrat and M. Stewart (1993) Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use. Vox Sang. 65, 271-278.
22. Hogman, C. F., L. Eriksson, J. Wallvik and J. M. Payrat (1997) Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system. Vox Sang. 73, 212-219.
23. Standefer, J. C. and D. Vanderjagt (1977) Use of tetramethylbenzidine in plasma hemoglobin assay. Clin. Chem. 23, 749-751.
24. Sass, M. D., C. J. Caruso and D. R. Axelrod (1968) Metabolic changes in stored blood measured by methylene blue. Clin. Chim. Acta 20, 105-110.
25. Greenwalt, T. J. and F. O. Lau (1978) Evaluation of toluidine blue for measuring erythrocyte membrane loss during in vivo ageing. Br. J. Hematol. 39, 545-50.
26. vanSteveninck, J., L. L. Trannoy, G. A. J. Besselink, T. M. A. R. Dubbelman, A. Brand, D. de Korte, A. J. Verhoeven and J. W. M. Lagerberg (2000) Selective protection of RBCs against photodynamic damage by the band 3 ligand dipyridamole. Transfusion 40, 1330-1336.
27. Mustonen, P., J. Y. Lehtonen and P. K. Kinnunen (1998) Binding of quinacrine to acidic phospholipids and pancreatic phospholipase A2. Effects on the catalytic activity of the enzyme. Biochemistry 37, 12051-12057.
28. Schoene, N. W. (1978) Properties of platelet phospholipase A2. Adv. Prostaglandin Thromboxane Res. 3, 121-126.
29. Young, P. R., R. I. Ma, P. Marfey and N. R. Kallenbach (1981) Frameshift mutagenesis of 9-aminoacridine derivatives in Salmonella typhimurium. Murat. Res. 90, 1-10.
30. Weisholtz, S. J., P. A. McBride, H. W. Murray and M. K. Shear (1982) Quinacrine-induced psychiatric disturbances. South. Med. J. 75, 359-360.
31. Jaeger, A., P. Sauder, J. Kopferschmitt and F. Flesch (1987) Clinical features and management of poisoning due to antimalarial drugs. Med. Toxicol. Adverse Drug Exp. 2, 242-273.